M&A Lawyers Line Up for Major Pharma Deals

, The Am Law Daily

   | 0 Comments

Valeant launched a $45.7 billion hostile takeover bid for Botox-maker Allergan, while Novartis announced a series of transactions with GlaxoSmithKline and Eli Lilly.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202652185196

Thank you!

This article's comments will be reviewed.